Zhou et al. [11] found that IgG4-RD patients (including IgG4-ROD patients) with high serum IgE levels at baseline were more likely to have higher disease activity and higher disease relapse rates. This evidence concerns the gene IGHE and immunoglobulin G4-related sclerosing disease.